Pan-Asia Index Rebalances/ Events/ Delta One, Periscope Analytics

Brian Freitas

Highly experienced ex-Delta One trader with 17 years of experience trading arbitrage and related strategies across Asian markets.

Exempt Financial Adviser (EFA) under CrossASEAN Research Pte Ltd.

It is important to note that the information provided by Periscope Analytics is based on publicly available data and own knowledge, which has been gathered and synthesized from a variety of sources. While every effort has been made to ensure the accuracy and completeness of the information provided, it is not guaranteed to be free from errors or omissions.

All forecasts and estimates are based on information that has been obtained from public sources that are considered to be reliable. The sources include, but are not limited to, company announcements, exchange filings, ETF and other passive investment vehicle holdings, and free float and volume data from third-party data providers. Periscope Analytics does not guarantee the accuracy and completeness of the forecasts, estimates and/or other information.

Pan-Asia Index Rebalances/ Events/ Delta One

KOSPI200 Index Rebalance Preview: Review Period Nearly Complete, Nine (Or Ten) Possible Changes

What the Locals Expect to Be Included or Excluded in the MSCI Korea, KOSPI200, & KOSDAQ150 Indices

KOSPI200 Index Rebalance: No Surprises Here, but Decent Impact Expected

SK Biopharmaceuticals - KOSPI200 Inclusion Confirmed, Large Impact Expected

KOSPI200 Index Rebalance Preview - Positioning Begins for December

SK Biopharmaceuticals - Index Fast Entry Possibilities: KOSPI200, FTSE, MSCI

Index Rebalance

Shinpoong Pharmaceutical / Index Rebalance

The Korea Exchange (KRX) will announce the results of the December 2020 review of the <a href="https://www.smartkarma.com/entities/korea-stock-exchange-kospi-200-index" target="_blank" data-smartkarma-citation="entities:26021:1" rel="noopener">Korea Stock Exchange Kospi 200 Index (KOSPI2 INDEX)</a> in November. The constituent changes will be effective from 11 December 2020 and the rebalancing trades will need to be done at the closing auction on 10 December 2020.At the current time, we see nine stocks being added to and deleted from the index with another three stocks as very close adds and deletes. This takes into the account the inclusion of <a href="https://www.smartkarma.com/entities/sk-biopharmaceuticals-co-ltd" target="_blank" data-smartkarma-citation="entities:28966:1" rel="noopener">SK Biopharmaceuticals (326030 KS)</a> as a Fast Entry into the index and exclusion of <a href="https://www.smartkarma.com/entities/kiswire-ltd" target="_blank" data-smartkarma-citation="entities:2093:1" rel="noopener">Kiswire Ltd (002240 KS)</a> on 10 September.The expected inclusions have outperformed the expected exclusions, and the <a href="https://www.smartkarma.com/entities/korea-stock-exchange-kospi-200-index" target="_blank" data-smartkarma-citation="entities:26021:1" rel="noopener">Korea Stock Exchange Kospi 200 Index (KOSPI2 INDEX)</a>, by a wide margin over the last 4 months. If the short sell ban expires on 15 September, stocks that have seen a sharp run up could be vulnerable to profit taking and short selling. Reduce existing positions over the next couple of weeks as we near the decision point on whether the short sell ban will stay in place or will be extended.

The Korea Exchange (KRX) will announce the results of the December 2020 review of the Korea Stock Exchange Kospi 200 Index (KOSPI2 INDEX) in November. The constituent changes will be effective from 11 December 2020 and the rebalancing trades will need to be done at the closing auction on 10 December 2020.At the current time, we see nine stocks being added to and deleted from the index with another three stocks as very close adds and deletes. This takes into the account the inclusion of SK Biopharmaceuticals (326030 KS) as a Fast Entry into the index and exclusion of Kiswire Ltd (002240 KS) on 10 September.The expected inclusions have outperformed the expected exclusions, and the Korea Stock Exchange Kospi 200 Index (KOSPI2 INDEX), by a wide margin over the last 4 months. If the short sell ban expires on 15 September, stocks that have seen a sharp run up could be vulnerable to profit taking and short selling. Reduce existing positions over the next couple of weeks as we near the decision point on whether the short sell ban will stay in place or will be extended.

Korea Stock Exchange KOSPI 200 (KOSPI2 INDEX EQUITY)

KOSPI200 지수 리밸런싱 미리보기: 아웃퍼폼 종목 추가, 삭제; 공매도 금지, 와일드카드